Palla Pharma Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Palla Pharma Ltd with three other
pharmaceutical manufacturers in Australasia:
Immuron Limited
(2019
sales of 2.92 million Australian Dollars [US$2.25 million]
of which 82%
was HyperImmune Products),
Incannex Healthcare Ltd
(1.18 million Australian Dollars [US$908,609.07 ]
), and
Orthocell Ltd
(956,472.00 Australian Dollars [US$737,449.48 ]
).
Sales Analysis.
Palla Pharma Ltd reported sales of A$54.84 million (US$42.28 million)
for the
year ending
December of 2019.
This
represents
an
increase of 17.8%
versus 2018, when the company's sales were A$46.56 million.
This was the fourth straight year of sales growth at Palla Pharma Ltd.